Metvixia FDA Approval History
FDA Approved: Yes (Discontinued) (First approved July 27, 2004)
Brand name: Metvixia
Generic name: methyl aminolevulinate hydrochloride
Dosage form: Cream
Company: Galderma Laboratories, L.P.
Treatment for: Keratosis
Marketing Status: Discontinued
Metvixia (methyl aminolevulinate hydrochloride) is a porphyrin precursor used in combination with the Aktilite CL128 lamp for treatment of actinic keratoses.
Development Timeline for Metvixia
|Jun 27, 2008||Photocure Receives FDA Approval for Metvixia/Aktilite Photodynamic Therapy|
|Jul 27, 2004||FDA Approves Metvixia for Actinic Keratosis|
|Jun 17, 2004||U.S. New Drug Application Approval Expected for Metvix|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.